Conquer Aging: Risk-Weighted ApoB Is A Better Predictor For CVD Risk Than Traditional Measures

🟢
Peer-Reviewed Research
C
Conquer Aging

Video Summary · March 15, 2026

View Full Protocol →

Key Takeaways

  • Use risk-weighted ApoB as a more accurate predictor of cardiovascular disease (CVD) risk compared to traditional metrics like LDL or non-HDL cholesterol.
  • Include triglycerides (VLDL) and lipoprotein A in your heart disease risk evaluation for a more comprehensive assessment.
  • Consult with your healthcare provider to implement Dr. Elias Bjornson’s equation for assessing CVD risk.

Bottom Line

For a clearer understanding of your heart disease risk, prioritize using risk-weighted ApoB alongside triglycerides and lipoprotein A in your evaluations.

Explore More

Watch the Full Video

Medical Disclaimer

This article is for informational purposes only and does not constitute medical advice. The research summaries presented here are based on published studies and should not be used as a substitute for professional medical consultation. Always consult a qualified healthcare provider before making any changes to your health regimen.

⚡ Research Insider Weekly

Peer-reviewed health research, simplified. Early access findings, clinical trial alerts & regulatory news — delivered weekly.

No spam. Unsubscribe anytime. Powered by Beehiiv.

From Our Research Network

Part of the Evidence-Based Research Network

Similar Posts